Skip to content


As of September 2014, my byline has changed: Allison Curley is now Allison Marin.



Clozapine and Long-Acting Injectable Antipsychotics Best at Schizophrenia Relapse Prevention

Most DRG Sensory Neurons Are Modality-Specific, Not Polymodal

DREADD Inhibition of Nociceptors: Interpret Results With Caution

Tiny Population of Oxytocin Neurons Controls Analgesia in Rats

Stress Regulation Gene Drives Development and Maintenance of Chronic Pain in Mice

Cytokine CSF1 Identified as a Key Signal From Injured Sensory Neurons to Microglia

Innovations in Spinal Cord Tumor Surgery

Spinal Inhibitory Interneuron Populations Identified as Gatekeepers of Pain and Itch

Persistent Mechanical Pain: Delving into Dorsal Horn Circuitry

Stem Cells Quell Neuropathic Pain in Mice

The Brain Circuitry of Relational Memory Impairment in Schizophrenia

Sex Differences in Immune Cell Mediation of Pain

Long-Acting Injectable Beats Pills to Head Off Early Psychosis Relapse

Progressive Brain Loss in Schizophrenia? New Evidence to Consider

Truncated Mu-Opioid Receptor Mediates Analgesia

Can Smoking Tobacco Lead to Schizophrenia?

GABAergic, Glutamatergic Genes Linked to CNVs in Schizophrenia

Move Over Alpha4: Nicotinic Receptor Alpha6 Subunit Identified as Potential Pain Target

NMDA Receptor Antibody False Positives in Schizophrenia

A New Optogenetics Approach: Creation of a Rhodopsin/Mu-Opioid Receptor Chimera

Transcranial Direct Current Stimulation for Chronic Low Back Pain: Hope or Hype?

New Antipsychotic Drug? Bypassing the NMDA Receptor with mGluR5

Cross-Talk Between Pain and Opioid Analgesia Signaling Pathways Identified

MRS Study Finds Lower GABA Levels in Older People with Schizophrenia

Mind Over Mouse: Human Thoughts Control Gene Expression in Mice

Unpacking the “Placebo Problem” in Antipsychotic Drug Trials

Blood Test Predicts Conversion to Psychosis in Preliminary Study

Evidence Mounts for the Maternal Inflammation Hypothesis of Schizophrenia

Mice in Pain Lose Drive, Show Changes in Brain Circuits Important for Motivation

Bigger Schizophrenia GWAS Reports More Than 100 Hits

Mycobacteria Use Angiotensin Receptor Pathway to Produce Painless Infections

Lipid Kinase Emerges as Novel Analgesic Target

Toxineering: New Tool for Harnessing the Power of Nature’s Poisons

Drug Permits the Extinction of Distant Traumatic Memories

SRF Community Assesses U.S. Funding Crisis

OPPERA Sings: Risk Factors for Jaw Pain Revealed in Large Prospective Study

Big Changes Coming to NIH-Funded Brain Banks

Opinions Mixed on Future for Lilly’s mGluR2/3 Agonist for Schizophrenia

ErbB4 Deletion Models Aspects of Schizophrenia

Forty-Year Study Reveals Patterns of Cognitive Decline in Schizophrenia

Rare CNVs Suggest a Role for Clinical Microarray Testing in Schizophrenia

Meta-Analysis Ranks Antipsychotics on Efficacy, Side Effects

Less Is More: Antipsychotic Dose After First-Episode Psychosis

Behavioral Intervention Leads to Weight Loss in Psychiatric Illnesses

The CAINS Is Able: New Schizophrenia Negative Symptom Rating Scale Debuts

Schizophrenia Gene Suspect Affects Fetal Brain

Exploring Mechanisms for the Bad Behavior of Atypical Antipsychotics

Attenuated Psychosis Syndrome Left Out of DSM-5 Main Text

Back to Reality: Computerized Cognitive Training Lends a Hand to Schizophrenia



Ran Proteins in Health and Disease

Proteasome Subunits: PSM Proteins

DEAD-Box RNA Helicases

Microtubule-Associated Proteins (MAPs): Life’s Mini Conveyor Belts



Creating Consensus on Bioethics

Failure to Replicate Goes Under the Microscope

Linking Early Life Stress, Pain, and Exercise

The Nociceptive Nature of Histone Deacetylase

Refining Schizophrenia Drug Trials

Reports From Schizophrenia Clinical Drug Trials

New Tools for Rational Drug Design

Schizophrenia Grab Bag

The Future of Psychiatric Genetics Part 1 and Part 2

The Influence of Genetics on Psychiatric Nosology

Schizophrenia in DSM-5 and ICD-11

Olfactory Neurons and Suspect SNPs in Psychotic Disorders